Mark B. Meyer

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

John J. Rinehart, Alex A. Adjei, Patricia LoRusso et al. · Journal of Clinical Oncology · 2004 · 639 citations

Medicine, Oncology, Pharmacology +16

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Patricia LoRusso, Alex A. Adjei, Mary Varterasian et al. · Journal of Clinical Oncology · 2005 · 399 citations

Medicine, Oncology, Pharmacology +17

Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D–induced inhibition of bone mineralization

Liesbet Lieben, Ritsuko Masuyama, Sophie Torrekens et al. · Journal of Clinical Investigation · 2012 · 367 citations · Full text

Medicine, Endocrinology, Nutritional Sciences +17

CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis

Lu Wang, Zibo Zhao, Mark B. Meyer et al. · Cancer Cell · 2014 · 258 citations · Full text

Medicine, Cancer Biology, Molecular Biology +12

The Human Transient Receptor Potential Vanilloid Type 6 Distal Promoter Contains Multiple Vitamin D Receptor Binding Sites that Mediate Activation by 1,25-Dihydroxyvitamin D3 in Intestinal Cells

Mark B. Meyer, Makoto Watanuki, Sung Tae Kim et al. · Molecular Endocrinology · 2006 · 222 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16